Insider Transactions in Q4 2023 at Generation Bio Co. (GBIO)
Insider Transaction List (Q4 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 08
2023
|
Dannielle Appelhans |
BUY
Open market or private purchase
|
Indirect |
7,363
+50.0%
|
$7,363
$1.79 P/Share
|
|
Dec 08
2023
|
Dannielle Appelhans |
BUY
Open market or private purchase
|
Direct |
637
+4.8%
|
$637
$1.82 P/Share
|
|
Dec 04
2023
|
Dannielle Appelhans |
BUY
Open market or private purchase
|
Direct |
12,000
+50.0%
|
$12,000
$1.5 P/Share
|
|
Dec 04
2023
|
Charles A Rowland Jr |
BUY
Open market or private purchase
|
Direct |
150,000
+21.91%
|
$150,000
$1.5 P/Share
|
|
Dec 01
2023
|
Donald William Nicholson |
BUY
Open market or private purchase
|
Direct |
100,000
+31.89%
|
$100,000
$1.44 P/Share
|
|
Dec 01
2023
|
Charles A Rowland Jr |
BUY
Open market or private purchase
|
Direct |
192,960
+33.4%
|
$192,960
$1.31 P/Share
|
|
Dec 01
2023
|
Anthony G. Quinn |
BUY
Open market or private purchase
|
Direct |
88,495
+50.0%
|
$88,495
$1.41 P/Share
|
|
Oct 15
2023
|
Antoinette Paone CHIEF OPERATING OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
1,211
-17.2%
|
$3,633
$3.24 P/Share
|
|
Oct 15
2023
|
Antoinette Paone CHIEF OPERATING OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
4,125
+36.95%
|
-
|
|
Oct 15
2023
|
Douglas Kerr CHIEF MEDICAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
2,183
-0.59%
|
$6,549
$3.24 P/Share
|
|
Oct 15
2023
|
Douglas Kerr CHIEF MEDICAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
7,437
+1.96%
|
-
|
|
Oct 15
2023
|
Geoff Mcdonough PRESIDENT AND CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
10,395
-0.8%
|
$31,185
$3.24 P/Share
|
|
Oct 15
2023
|
Geoff Mcdonough PRESIDENT AND CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
23,437
+1.77%
|
-
|
|
Oct 15
2023
|
Matthew Norkunas CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
2,675
-3.28%
|
$8,025
$3.24 P/Share
|
|
Oct 15
2023
|
Matthew Norkunas CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
9,111
+9.68%
|
-
|
|
Oct 15
2023
|
Tracy Zimmermann CHIEF DEVELOPMENT OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
2,183
-5.66%
|
$6,549
$3.24 P/Share
|
|
Oct 15
2023
|
Tracy Zimmermann CHIEF DEVELOPMENT OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
7,437
+16.17%
|
-
|
|
Oct 15
2023
|
Matthew Stanton CHIEF SCIENTIFIC OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
2,183
-0.92%
|
$6,549
$3.24 P/Share
|
|
Oct 15
2023
|
Matthew Stanton CHIEF SCIENTIFIC OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
7,437
+3.05%
|
-
|
|
Oct 15
2023
|
Phillip Samayoa CHIEF STRATEGY OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
1,211
-1.12%
|
$3,633
$3.24 P/Share
|
|
Oct 15
2023
|
Phillip Samayoa CHIEF STRATEGY OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
4,125
+3.66%
|
-
|